T1	Age 2 13	70-year-old
T2	Sex 14 17	man
T3	Clinical_event 22 30	referred
E1	Clinical_event:T3 
T4	Nonbiological_location 38 46	hospital
T5	Biological_structure 51 58	gastric
T6	Disease_disorder 59 65	cancer
E2	Disease_disorder:T6 
R1	MODIFY Arg1:T5 Arg2:E2	
T7	Diagnostic_procedure 104 130	esophagogastroduodenoscopy
E3	Diagnostic_procedure:T7 
T8	Diagnostic_procedure 131 136	(EGD)
E4	Diagnostic_procedure:T8 
R2	IDENTICAL Arg1:E4 Arg2:E3	
T9	History 138 168	No significant medical history
T10	Sign_symptom 192 199	dysuria
E5	Sign_symptom:T10 
T11	Detailed_description 200 229	caused by bladder contraction
R3	MODIFY Arg1:T11 Arg2:E5	
T12	Diagnostic_procedure 239 249	laboratory
E6	Diagnostic_procedure:T12 
T13	Diagnostic_procedure 264 282	serum level of AFP
E7	Diagnostic_procedure:T13 
T14	Lab_value 286 296	32.3 ng/mL
R4	MODIFY Arg1:T14 Arg2:E7	
R5	SUB_PROCEDURE Arg1:E7 Arg2:E6	
T15	Diagnostic_procedure 396 420	carcinoembryonic antigen
E8	Diagnostic_procedure:T15 
T16	Diagnostic_procedure 421 426	(CEA)
E9	Diagnostic_procedure:T16 
T17	Diagnostic_procedure 431 456	carbohydrate antigen 19-9
E10	Diagnostic_procedure:T17 
T18	Diagnostic_procedure 457 465	(CA19-9)
E11	Diagnostic_procedure:T18 
R6	IDENTICAL Arg1:E11 Arg2:E10	
R7	IDENTICAL Arg1:E9 Arg2:E8	
R8	SUB_PROCEDURE Arg1:E8 Arg2:E6	
R9	SUB_PROCEDURE Arg1:E10 Arg2:E6	
T19	Lab_value 329 349	no other abnormality
R10	MODIFY Arg1:T19 Arg2:E8	
R11	MODIFY Arg1:T19 Arg2:E10	
T20	Coreference 467 470	EGD
E12	Coreference:T20 
R12	IDENTICAL Arg1:E12 Arg2:E3	
T21	Sign_symptom 503 507	mass
E13	Sign_symptom:T21 
T22	Detailed_description 487 502	ulcerofungating
R13	MODIFY Arg1:T22 Arg2:E13	
T23	Distance 482 486	5-cm
R14	MODIFY Arg1:T23 Arg2:E13	
T24	Detailed_description 517 550	comprised of three septate ulcers
R15	MODIFY Arg1:T24 Arg2:E13	
T25	Biological_structure 551 597	in the greater curvature of the gastric antrum
R16	MODIFY Arg1:T25 Arg2:E13	
T26	Diagnostic_procedure 601 625	pathological examination
E14	Diagnostic_procedure:T26 
T27	Biological_structure 629 654	endoscopic biopsy tissues
T28	Disease_disorder 715 729	adenocarcinoma
E15	Disease_disorder:T28 
T29	Detailed_description 707 714	tubular
R17	MODIFY Arg1:T29 Arg2:E15	
T30	Detailed_description 681 706	moderately differentiated
R18	MODIFY Arg1:T30 Arg2:E15	
R19	MODIFY Arg1:T27 Arg2:E14	
R20	MODIFY Arg1:E15 Arg2:E14	
T31	Diagnostic_procedure 757 776	computed tomography
E16	Diagnostic_procedure:T31 
T32	Biological_structure 742 756	abdominopelvic
R21	MODIFY Arg1:T32 Arg2:E16	
T33	Sign_symptom 798 802	mass
E17	Sign_symptom:T33 
T34	Biological_structure 790 797	gastric
R22	MODIFY Arg1:T34 Arg2:E17	
R23	MODIFY Arg1:E17 Arg2:E16	
T35	Detailed_description 803 823	with deep ulceration
R24	MODIFY Arg1:T35 Arg2:E17	
T36	Biological_structure 824 845	in the gastric antrum
R25	MODIFY Arg1:T36 Arg2:E17	
T37	Detailed_description 846 885	with perigastric lymph node enlargement
R26	MODIFY Arg1:T37 Arg2:E17	
T38	Sign_symptom 890 908	metastatic lesions
E18	Sign_symptom:T38 
A1	POLARITY E18 NEG
T39	Biological_structure 930 935	liver
T40	Biological_structure 937 941	lung
T41	Biological_structure 945 955	peritoneum
R27	MODIFY Arg1:T39 Arg2:E18	
R28	MODIFY Arg1:T40 Arg2:E18	
R29	MODIFY Arg1:T41 Arg2:E18	
T42	Biological_structure 961 966	chest
T43	Diagnostic_procedure 967 978	radiography
E19	Diagnostic_procedure:T43 
R30	MODIFY Arg1:T42 Arg2:E19	
T44	Sign_symptom 986 1009	no significant findings
E20	Sign_symptom:T44 
R31	MODIFY Arg1:E20 Arg2:E19	
T45	Therapeutic_procedure 1028 1039	gastrectomy
E21	Therapeutic_procedure:T45 
T46	Detailed_description 1011 1018	Radical
T47	Detailed_description 1019 1027	subtotal
R32	MODIFY Arg1:T47 Arg2:E21	
R33	MODIFY Arg1:T46 Arg2:E21	
T48	Biological_structure 1045 1058	D2 lymph node
T49	Therapeutic_procedure 1059 1069	dissection
E22	Therapeutic_procedure:T49 
T50	Therapeutic_procedure 1086 1103	gastrojejunostomy
E23	Therapeutic_procedure:T50 
T51	Detailed_description 1074 1085	Billroth II
R34	MODIFY Arg1:T48 Arg2:E22	
R35	MODIFY Arg1:T51 Arg2:E23	
R36	SUB_PROCEDURE Arg1:E22 Arg2:E21	
R37	SUB_PROCEDURE Arg1:E23 Arg2:E21	
T52	Therapeutic_procedure 2366 2386	postoperative course
E24	Therapeutic_procedure:T52 
T53	Lab_value 2355 2365	uneventful
R38	MODIFY Arg1:T53 Arg2:E24	
T54	Clinical_event 2395 2405	discharged
E25	Clinical_event:T54 
T55	Date 2409 2428	postoperative day 9
E26	Date:T55 
T56	Date 2430 2445	Two weeks later
E27	Date:T56 
T57	Diagnostic_procedure 2451 2460	HCG level
E28	Diagnostic_procedure:T57 
T58	Lab_value 2465 2475	176 mIU/mL
R39	MODIFY Arg1:T58 Arg2:E28	
T59	Diagnostic_procedure 2512 2521	AFP level
E29	Diagnostic_procedure:T59 
T60	Lab_value 2526 2536	10.0 ng/mL
R40	MODIFY Arg1:T60 Arg2:E29	
T61	Medication 2552 2573	adjuvant chemotherapy
E30	Medication:T61 
T62	Medication 2579 2591	capecitabine
E31	Medication:T62 
R41	MODIFY Arg1:E31 Arg2:E30	
T63	Frequency 2538 2548	Six cycles
R42	MODIFY Arg1:T63 Arg2:E30	
T64	Dosage 2657 2690	2500 mg/m2 per day for 14 d/cycle
R43	MODIFY Arg1:T64 Arg2:E31	
T65	Date 2692 2708	After two cycles
E32	Date:T65 
T66	Diagnostic_procedure 2714 2725	β-HCG level
E33	Diagnostic_procedure:T66 
T67	Lab_value 2742 2752	< 3 mIU/mL
R44	MODIFY Arg1:T67 Arg2:E33	
T68	Sign_symptom 2795 2805	recurrence
E34	Sign_symptom:T68 
T69	Sign_symptom 2809 2827	distant metastasis
E35	Sign_symptom:T69 
T70	Date 2848 2854	4-year
E36	Date:T70 
T71	Clinical_event 2855 2878	postoperative follow-up
E37	Clinical_event:T71 
T72	Biological_structure 1133 1150	resected specimen
T73	Sign_symptom 1168 1175	lesions
E38	Sign_symptom:T73 
T74	Lab_value 1161 1167	double
R45	MODIFY Arg1:T74 Arg2:E38	
T75	Detailed_description 1191 1243	a 5.8 cm × 3.2 cm ulcerofungating mass in the antrum
T76	Detailed_description 1250 1270	extensive hemorrhage
R46	MODIFY Arg1:T75 Arg2:E38	
R47	MODIFY Arg1:T76 Arg2:E38	
T77	Detailed_description 1286 1294	fibrosis
R48	MODIFY Arg1:T77 Arg2:E38	
T78	Color 1275 1285	light gray
R49	MODIFY Arg1:T78 Arg2:T77	
T79	Detailed_description 1315 1357	a nearby 2.5 cm × 2.0 cm ulcerative lesion
R50	MODIFY Arg1:T79 Arg2:E38	
T80	Sign_symptom 1428 1439	tumor cells
E39	Sign_symptom:T80 
T81	Detailed_description 1420 1427	bizarre
T82	Detailed_description 1407 1418	pleomorphic
T83	Lab_value 1388 1403	massive numbers
R51	MODIFY Arg1:T83 Arg2:E39	
R52	MODIFY Arg1:T81 Arg2:E39	
R53	MODIFY Arg1:T82 Arg2:E39	
T84	Detailed_description 1445 1499	hemorrhage (syncytiotrophoblasts and cytotrophoblasts)
R54	MODIFY Arg1:T84 Arg2:E39	
T85	Diagnostic_procedure 1535 1577	Hematoxylin and eosin (HE)-stained tissues
E40	Diagnostic_procedure:T85 
T86	Biological_structure 1603 1612	cytoplasm
T87	Color 1596 1602	purple
T88	Shape 1589 1595	bubbly
R55	MODIFY Arg1:T87 Arg2:T86	
R56	MODIFY Arg1:T88 Arg2:T86	
T89	Biological_structure 1623 1629	nuclei
T90	Detailed_description 1635 1656	magnification of 40 ×
T91	Detailed_description 1674 1679	100 ×
R57	MODIFY Arg1:T90 Arg2:E40	
R58	MODIFY Arg1:T91 Arg2:E40	
R59	MODIFY Arg1:T86 Arg2:E40	
R60	MODIFY Arg1:T89 Arg2:E40	
T92	Lab_value 1617 1622	giant
R61	MODIFY Arg1:T92 Arg2:T89	
T93	Coreference 1698 1703	tumor
E41	Coreference:T93 
R62	IDENTICAL Arg1:E41 Arg2:E39	
T94	Biological_structure 1717 1742	proper muscle layer (T2a)
R63	MODIFY Arg1:T94 Arg2:E41	
T95	Sign_symptom 1747 1757	metastasis
E42	Sign_symptom:T95 
T96	Biological_structure 1768 1802	in four of 56 regional lymph nodes
R64	MODIFY Arg1:T96 Arg2:E42	
T97	Diagnostic_procedure 1809 1837	Immunohistochemical staining
E43	Diagnostic_procedure:T97 
T98	Lab_value 1845 1870	positive immunoreactivity
T99	Diagnostic_procedure 1875 1905	β-human chorionic gonadotropin
E44	Diagnostic_procedure:T99 
T100	Diagnostic_procedure 1950 1953	AFP
E45	Diagnostic_procedure:T100 
T101	Lab_value 1929 1945	focal positivity
R65	MODIFY Arg1:T101 Arg2:E45	
R66	MODIFY Arg1:T98 Arg2:E44	
R67	SUB_PROCEDURE Arg1:E44 Arg2:E43	
R68	SUB_PROCEDURE Arg1:E45 Arg2:E43	
T102	Disease_disorder 2017 2032	choriocarcinoma
E46	Disease_disorder:T102 
T103	Biological_structure 2009 2016	gastric
R69	MODIFY Arg1:T103 Arg2:E46	
T104	Disease_disorder 2151 2165	adenocarcinoma
E47	Disease_disorder:T104 
T105	Biological_structure 2143 2150	tubular
T106	Disease_disorder 2079 2093	adenocarcinoma
E48	Disease_disorder:T106 
T107	Detailed_description 2065 2078	AFP-producing
R70	MODIFY Arg1:T107 Arg2:E48	
R71	MODIFY Arg1:T105 Arg2:E47	
T108	Biological_structure 2173 2205	extended to the submucosal layer
R72	MODIFY Arg1:T108 Arg2:E47	
R73	MODIFY Arg1:T4 Arg2:E1	
*	OVERLAP E1 E2 E3
R74	AFTER Arg1:E3 Arg2:E5	
R75	BEFORE Arg1:E5 Arg2:E6	
*	OVERLAP E6 E12 E13 E14 E15
R76	BEFORE Arg1:E15 Arg2:E16	
*	OVERLAP E16 E17 E18 E19 E20
R77	BEFORE Arg1:E20 Arg2:E21	
R78	BEFORE Arg1:E21 Arg2:E38	
R79	MODIFY Arg1:T72 Arg2:E38	
*	OVERLAP E38 E39 E40 E42 E41 E43 E46 E48 E47
R80	BEFORE Arg1:E47 Arg2:E24	
R81	BEFORE Arg1:E24 Arg2:E25	
*	OVERLAP E25 E26
R82	BEFORE Arg1:E26 Arg2:E27	
*	OVERLAP E27 E28 E29
R83	BEFORE Arg1:E29 Arg2:E30	
R84	BEFORE Arg1:E30 Arg2:E32	
*	OVERLAP E32 E33
R85	BEFORE Arg1:E33 Arg2:E34	
A2	POLARITY E34 NEG
A3	POLARITY E35 NEG
*	OVERLAP E34 E35 E36 E37
T109	Lab_value 2730 2738	declined
E49	Lab_value:T109 
R86	MODIFY Arg1:E49 Arg2:E33	
